Hospira Injections Recalled Due to Presence of Glass Particles

October 3, 2013

Hospira, Inc. has initiated a voluntary nationwide recall of three lots of injections where glass strands have been identified affixed to the inside of the vial walls. One lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL) and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL) have been recalled.

The affected lots were distributed nationwide between June 2013 and September 2013 to wholesalers/distributors, hospitals and pharmacies. To date, Hospira has not received reports of any adverse events associated with this issue for these lots, however, there is potential for the glass particulates to dislodge into the solution.

Anyone with an existing inventory should stop use and distribution, quarantine the product immediately and call Stericycle at 1.877.497.3125 between the hours of 8:00 am to 5:00 pm ET, Monday through Friday, to arrange for the return of the product. Replacement product from other lots is available.

Read the MedWatch Safety Alert for more information about the recalled injections and the consequences of administering an injectable with the presence of foreign particulates.